Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis
- 11 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 99 (6), 813-820
- https://doi.org/10.1002/bjs.8743
Abstract
Background: Elderly patients with breast cancer are under‐represented in clinical studies. It is not known whether treatment guidelines, based on clinical trials, can be extrapolated to this population. The aim of this study was to assess adherence to treatment guidelines by age at diagnosis, and to examine age‐specific survival in relation to adherence to guidelines. Methods: Patients with early‐stage breast cancer aged either less than 65 years, or 75 years or more, diagnosed between 2005 and 2008, were identified from the Netherlands Cancer Registry. Adherence to treatment guidelines for breast and axillary surgery, radiotherapy, chemotherapy and endocrine therapy was determined. Non‐adherence to the guidelines was defined as overtreatment or undertreatment. The primary endpoint was overall survival, assessed by means of an instrumental variable, the comprehensive cancer centre region. Results: Some 24 959 patients younger than 65 years and 6561 patients aged 75 years or more were included in the analysis. Median follow‐up was 2·8 years. Compared with patients younger than 65 years, those aged at least 75 years were less frequently treated in concordance with guidelines: 62·0 per cent (15 487 patients) versus 55·6 per cent (3647 patients) (P < 0·001). In both age groups, most patients received at least three of five treatment modalities in concordance with guidelines: 98·8 per cent (24 652 patients) and 93·8 per cent (6152 patients) respectively. Analysis of survival using the instrumental variable showed that adherence to guidelines was not associated with overall survival in patients younger than 65 years (P = 0·601) or those aged at least 75 years (P = 0·190). Conclusion: Adherence to treatment guidelines was affected by age at diagnosis. However, adherence to the guidelines was not associated with overall survival in either age group. Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.Keywords
This publication has 22 references indexed in Scilit:
- Lack of Survival Gain for Elderly Women with Breast CancerThe Oncologist, 2011
- Effects of guideline adherence in primary breast cancer–A 5-year multi-center cohort study of 3976 patientsThe Breast, 2010
- Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patientsBreast Cancer Research and Treatment, 2010
- EORTC elderly task force position paper: Approach to the older cancer patientEuropean Journal Of Cancer, 2010
- Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric OncologyThe Lancet Oncology, 2007
- Caring for older women with breast cancer: can observational research fill the clinical trial gap?JNCI Journal of the National Cancer Institute, 2006
- Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: A population-based studyEuropean Journal Of Cancer, 2005
- Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patientsBritish Journal of Cancer, 2004
- When are observational studies as credible as randomised trials?The Lancet, 2004
- Undertreatment Strongly Decreases Prognosis of Breast Cancer in Elderly WomenJournal of Clinical Oncology, 2003